Increasing awareness and knowledge of Alpha-gal Syndrome in the United States
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The contract focuses on increasing awareness and understanding of alpha-gal syndrome (AGS), a growing but not nationally reportable allergic condition in the United States. The primary goal is to enhance AGS surveillance, improve patient care, and boost public awareness through a structured set of strategies. The core requirement is the formation of an association of AGS professionals (SHARE) aimed at sharing the latest knowledge among public health agencies, researchers, and advocacy groups to strengthen the health response and patient outcomes. Additional optional strategies include educating healthcare providers and at-risk groups such as outdoor workers and enthusiasts (EDUCATE), as well as improving public health surveillance with attention to populations or areas with limited access to specialized care and considering social determinants of health (TRACK). Applicants must participate in the mandatory SHARE strategy, while EDUCATE and TRACK efforts may be included to further support the contract’s objectives. The initiative is managed by the Centers for Disease Control’s National Center for Emerging and Zoonotic Infectious Diseases under the Department of Health and Human Services. Its purpose aligns with advancing public health knowledge and response capabilities concerning AGS by fostering collaboration, disseminating educational resources, and improving surveillance systems. Contact for this opportunity is provided through CDC personnel to support applicants seeking further information.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
The purpose of this NOFO is to improved awareness and knowledge of alpha-gal syndrome (AGS) in the United States. AGS is an emerging condition and is not nationally notifiable. This NOFO seeks to improve AGS surveillance, patient care, and public awareness and understanding. The NOFO strategies are to 1) SHARE - Formation of an association of AGS professionals to disseminate latest knowledge of AGS among stakeholders, including public health agencies, academic researchers, and advocacy groups, in order to improve patient care for AGS and the public health response. 2) EDUCATE - Create AGS communications targeted at the general public, AGS patients, or persons at higher risk for tick encounters (outdoor enthusiasts, dog owners, outdoor workers, etc.). Create communications targeted at healthcare providers including educational resources and training. 3) TRACK - Conduct active or enhances public health surveillance for AGS. This strategy could involve patient populations or geographical locations with limited access to specialized healthcare provider care. Social Determinants of Health impacts could be considered as well. Please note that applicants must apply for strategy number 1 (SHARE) and that strategies 2 (EDUCATE) and 3 (TRACK) are optional.
